American Portfolios Advisors’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.33M | Sell |
8,744
-2,513
| -22% | -$671K | 0.1% | 208 |
|
|
2022
Q2 | $2.3M | Sell |
11,257
-44
| -0.4% | -$8.97K | 0.09% | 220 |
|
|
2022
Q1 | $2.38M | Buy |
11,301
+157
| +1% | +$33.1K | 0.08% | 254 |
|
|
2021
Q4 | $2.67M | Buy |
11,144
+25
| +0.2% | +$6K | 0.09% | 225 |
|
|
2021
Q3 | $3.15M | Buy |
11,119
+769
| +7% | +$218K | 0.12% | 173 |
|
|
2021
Q2 | $3.58M | Buy |
10,350
+3
| +0% | +$1.04K | 0.14% | 140 |
|
|
2021
Q1 | $2.89M | Buy |
10,347
+20
| +0.2% | +$5.6K | 0.13% | 155 |
|
|
2020
Q4 | $2.53M | Sell |
10,327
-5
| -0% | -$1.22K | 0.13% | 154 |
|
|
2020
Q3 | $2.93M | Sell |
10,332
-52
| -0.5% | -$14.8K | 0.17% | 120 |
|
|
2020
Q2 | $2.78M | Sell |
10,384
-751
| -7% | -$201K | 0.18% | 119 |
|
|
2020
Q1 | $3.52M | Sell |
11,135
-331
| -3% | -$105K | 0.29% | 72 |
|
|
2019
Q4 | $3.4M | Sell |
11,466
-473
| -4% | -$140K | 0.24% | 94 |
|
|
2019
Q3 | $2.78M | Buy |
11,939
+346
| +3% | +$80.6K | 0.23% | 100 |
|
|
2019
Q2 | $2.71M | Buy |
11,593
+9,982
| +620% | +$2.33M | 0.23% | 101 |
|
|
2019
Q1 | $381K | Buy |
1,611
+157
| +11% | +$37.1K | 0.04% | 436 |
|
|
2018
Q4 | $438K | Buy |
1,454
+30
| +2% | +$9.03K | 0.05% | 307 |
|
|
2018
Q3 | $503K | Buy |
1,424
+38
| +3% | +$13.4K | 0.06% | 310 |
|
|
2018
Q2 | $402K | Sell |
1,386
-19
| -1% | -$5.52K | 0.05% | 325 |
|
|
2018
Q1 | $385K | Buy |
1,405
+181
| +15% | +$49.6K | 0.06% | 328 |
|
|
2017
Q4 | $390K | Buy |
+1,224
| New | +$390K | 0.06% | 314 |
|